ImmunoCARE: Rapid, Accurate COVID Testing to Reduce Hospitalization of Immunocompromised Individuals
The investigators will examine whether a combination of at-home nucleic acid amplification tests, on-demand telemedicine, and delivery of prescriptions such as Paxlovid quickly after testing positive for COVID-19, can reduce severe outcomes and hospitalization of immunocompromised patients and those who are 65 years and older. They will also analyze whether these efforts lower the cost of care compared to standard of care.
Checked against the public recordLast updated Aug 8, 2025 · Source: ClinicalTrials.gov
What this study is about
- Purpose
- Other
- Study type
- Interventional
- Phase
- Not applicable
- Sponsor
- Scripps Translational Science Institute
- Interventions being studied
- Other: Access to Cue Health COVID-19 Remote testing and treatment for COVID-19
How this study is categorized
These labels come from structured fields and exact terms in the public record.
Who may be able to participate
Inclusion Criteria: * Living in the United States * 18 years or older * Can read and understand English * Use of smartphone with bluetooth, a camera and a compatible operating system (Android OS 9.0 or higher, Apple iOS 13.0 or higher) * Vaccinated against COVID-19 (completed at least the initial course, e.g. at least 2 doses of -Moderna or Pfizer, one dose of J\&J) * Willing and able to participate in study interventions including: 1. Use of smartphone, including camera and bluetooth 2. Upload verification of diagnosis, if needed 3. Completing Surveys 4. Use of Cue Health App 5. Use of MyDataHelps Web or App * Immunocompromised due to disease or therapy, including: 1. Symptomatic HIV 2. Graft versus host disease 3. Immunoglobulin deficiency/Immunodeficiency 4. Immunosuppressive therapy 5. Leukemia 6. Lymphoma (Hodgkin or non-Hodgkin) 7. Metastatic Cancer 8. Multiple Myeloma 9. Solid organ malignancy 10. Transplant, hematopoietic stem cell 11. Transplant, solid organ * Age 1. 65 years and older Option if under 65 to share claims data as a member of one of the following insurance providers: 1. Anthem BlueCross and BlueShield 2. Anthem BlueCross 3. Empire BlueCross BlueShield 4. Empire BlueCross 5. Wellpoint 6. Carelon 7. Unicare 8. Simply Healthcare Plans 9. National Government Services, Inc. 10. MMM 11. Health Sun 12. HealthLink 13. Amerigroup 14. Medicare 15. Medicaid 16. Or another partner that can provide claims data on participant's behalf Exclusion Criteria: -Unable to meet inclusion criteria
Important: This is the sponsor’s public criteria, not a determination of eligibility. The study team must review your individual situation.
U.S. locations
- Scripps ResearchLa Jolla, California
Source and freshness
Processed from ClinicalTrials.gov. Last public update: Aug 8, 2025. Always confirm current availability with the study team.